How to Buy Exact Sciences Stock

Exact Sciences Corp

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally.

Exact Sciences stock last closed at $84.95, up 1.32% from the previous day, and has increased 81.94% in one year. It has overperformed other stocks in the Diagnostics & Research industry by 0.86 percentage points. Exact Sciences stock is currently +190.23% from its 52-week low of $29.27, and -1.01% from its 52-week high of $85.82.

There are currently 180.39M shares of EXAS outstanding. The market capitalization of EXAS is $15.32B. In the past 24 hours, 953,855 EXAS shares were traded.

How to Buy Exact Sciences Stock

Not sure how to invest in Exact Sciences stock? Here's how.
  1. Figure out where to buy Exact Sciences stock: You need to decide on an online brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you figure out where to buy Exact Sciences stock.
  2. Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
  3. Deposit funds into your brokerage account: Select your payment method and add your info.
  4. Analyze Exact Sciences stock: The Exact Sciences ticker symbol is EXAS. Is Exact Sciences stock a good investment? Should you buy shares of EXAS? How do EXAS's underlying business fundamentals look? Do top analysts think Exact Sciences is a good buy? Why has EXAS's stock price moved recently? (Hint: Our stock market research tools can help you understand if EXAS is a good stock to buy).
  5. Make your EXAS buy order: Decide if you will purchase EXAS shares at the current market price or use a limit order to purchase EXAS stock at a particular price.
  6. Get notifications regarding your EXAS position: Create a watchlist to watch your investment in Exact Sciences shares.

Step 1: Figure out where to buy Exact Sciences stock

You will need an online brokerage account to access the NASDAQ market and buy EXAS shares.

A brokerage account is an investment account that enables you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

Based on our analysis, eToro is the best stock brokerage. eToro gives you:

  • You can invest in stocks with 0% commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
  • Access to world markets: From Tech to Healthcare, New York to Tokyo — you can fill your portfolio with stocks from the world's top stock exchanges.
  • Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other assets: Such as ETFs and cryptocurrencies.

Get $10 towards your stock purchase by signing up for an account with eToro today.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create a brokerage account

Now that you've selected the right brokerage, the next step is to fill out some personal details so you can buy EXAS today.

How to Start a New Brokerage Account on eToro

  1. Click here to get started.
  2. Provide your personal details to open your new trading account.
  1. Submit your details by clicking the "Create Account" button.
Get started with eToro today

Step 3: Deposit funds into your brokerage account

Now that you have finished signing up on investing apps, you need to deposit funds:

Check out the walkthrough below to see the process of depositing money into your new brokerage account.

Get started with eToro today

Step 4: Analyze Exact Sciences stock

Once you have decided on the best place to buy Exact Sciences stock, it's absolutely critical to research their stock before you buy, so you truly understand the risk as well as the opportunity.

Exact Sciences stock at a glance

EXAS Price
1w %
1y %
5y %
Fore. Rev. Growth
Fore. Earn. Growth
Market Cap
Next Earnings
Jul 31, 2023
Next Dividend

Fundamentals of EXAS

WallStreetZen was created to help part-time investors do better fundamental analysis in minutes instead of hours.

You can see all of the due diligence checks on EXAS's stock page.

What is the fair value of EXAS stock?

Investors use many financial metrics, analyses, models, and charts to gauge EXAS's fair value.

Using relative valuations measures:

  • EXAS may be overvalued based on its P/B ratio of 5.01x, relative to Diagnostics & Research industry P/B ratio of 4.01x

You can do more valuation analysis on EXAS's stock here.

EXAS Financial Summary

Positive Health Checks:

  • EXAS profit margin has gone up from -40.3% to -23.5% in the past year.
  • EXAS has cash burn of 273219000. It has enough cash and short-term investments to cover this for at least one year.
  • EXAS has $698.65M in cash and short term investments. This is enough to cover its annual cash burn of $273.22M.
  • There are more short-term assets than short-term liabilities on the EXAS balance sheet.

Negative Health Checks:

  • EXAS has a relatively high debt to equity ratio of 1.06.
  • There are more long-term liabilities than short-term assets on the EXAS balance sheet.
  • Total EXAS debt is higher than 5 years ago, relative to shareholder equity.

Is EXAS stock a Buy, Hold, or Sell, according to Wall Street analysts?

Out of 12 Wall Street analysts who give recommendations on EXAS, the consensus analyst rating on Exact Sciences is a Buy

Please note that analyst ratings are not recommendations, nor are they investment advice.

Latest EXAS Analyst Ratings

Patrick B Donnelly, a top 7% analyst from Citigroup maintains EXAS with a strong buy rating and raises their EXAS price target from $90.00 to $100.00, on May 11, 2023.

Derik De Bruin, a top 7% analyst from Bank of America maintains EXAS with a strong buy rating and raises their EXAS price target from $80.00 to $88.00, on May 10, 2023.

Dan Leonard, a top 7% analyst from Credit Suisse maintains EXAS with a hold rating and raises their EXAS price target from $70.00 to $75.00, on May 10, 2023.

Catherine Schulte, a top 4% analyst from Baird maintains EXAS with a buy rating and raises their EXAS price target from $92.00 to $99.00, on May 10, 2023.

Alex Nowark, a top 30% analyst from Craig-Hallum upgrades EXAS to a buy rating and raises their EXAS price target from $55.00 to $85.00, on May 10, 2023.

You can dive deeper into what analysts are projecting on the Exact Sciences stock forecast page.

EXAS Momentum

MACD Signal
MACD Histogram
Stochastic %K
Stochastic %D
StochRSI %K
StochRSI %D

Is EXAS Growing Revenue?

Last year, EXAS revenue was $2.20B. Over the past five year, EXAS's revenue has increased by 48.18% per year. This was faster than the Diagnostics & Research industry average of 15.12%.

You can analyze EXAS's earnings and revenue performance here.

What are EXAS insiders up to?

Over the past year, insiders at EXAS have sold more shares than they have bought.

James Edward Doyle, Director of EXAS, was the latest EXAS insider to sell. They sold $161,240.00 worth of EXAS shares on May 26, 2023.

Learn more about who owns EXAS stock here.

Can I get consistent income from EXAS stock?

No, Exact Sciences doesn't provide an income stream by paying out dividends.

What do other investors have to say about EXAS?

One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to learn what other traders have to say.

Step 5: Make your EXAS buy order

There are two primary options:

  • Market order: A market order is an order to buy or sell a stock at the best possible price.
    Market orders are usually fine.
  • Limit order: A limit order lets you buy or sell a security at a specific price (or better).
    If you want to make sure you're buying or selling at a particular dollar amount limit, place a limit order.

Hit the Open Trade button and eToro will execute the order.

If you need more assistance investing in stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Get notifications regarding your EXAS position

Now that you own some EXAS shares, you'll want to keep up with your investment.

Make a watchlist to see the latest developments about your EXAS stock.


How to Buy Stock in Exact Sciences

To reiterate, here are the 6 steps to buy Exact Sciences stock:

  1. Figure out where to buy Exact Sciences stock
  2. Create a brokerage account
  3. Deposit funds into your brokerage account
  4. Analyze Exact Sciences stock
  5. Make your EXAS buy order
  6. Get notifications regarding your EXAS position

If you are looking for a place to buy stocks, eToro is our recommended venue.

Get Started with eToro Today

If you want to keep an eye on your new investment in Exact Sciences, create your watchlist below.

$84.95+1.11 (+1.32%)
Updated Jun 5, 2023
Open eToro Account
$84.95+1.11 (+1.32%)
Updated Jun 5, 2023
Open eToro Account


How much does it cost to buy one Exact Sciences share?

As of Jun 5, 2023, it costs $84.95 to buy one share of Exact Sciences stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.118 shares of EXAS.

Get Started with eToro Today

Is now a good time to buy Exact Sciences stock?

According to 12 Wall Street analysts who monitor Exact Sciences, their consensus recommendation is to buy Exact Sciences stock.

What is the best way to buy Exact Sciences stock?

One way to place an order for Exact Sciences stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.